glp-1 advertising crackdown news GLP-1 ad battle: Ozempic and Wegovy maker on the Hims & Hers Super Bowl ad NCL Issues a Second Alert

GLP-1 vision loss lawsuits have recently been consolidated into their own MDL, providing a streamlined legal pathway for victims of NAION potentially linked to Ozempic and other weight loss and diabetes drugs

We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this communication

The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides

Expanding clinical research and addressing these questions will be essential for fully realizing the therapeutic potential of GLP-1RAs

Inflammation in the airway, altered mechanics and impaired response to medication contribute to these relationships